Ninehealth Medical: has repurchased 10.2287 million shares, using a total amount of funds of 411 million yuan.

On November 21st, Jiuan Medical announced that the company held the 27th meeting of the sixth board of directors on October 13, 2025, and reviewed and approved the "Proposal on the Company's Share Repurchase Plan". The source of funds for this repurchase comes from the company's own funds and repurchase special loan funds, with a total repurchase amount of no less than 300 million yuan and not more than 600 million yuan. The repurchase price of the shares is not more than 53.5 yuan per share, and the specific repurchase quantity is based on the actual number of shares repurchased when the repurchase period expires. As of November 21, 2025, the company has repurchased a total of 10.2287 million shares, accounting for 2.20% of the company's total share capital, with a repurchase price range of 39.598 yuan per share to 41.3 yuan per share, and a total of 411 million yuan in funds used.